AtriCure Executive and Leadership Team

Michael Carrel, the President & Chief Executive Officer at AtriCure, directs the company's overall strategic vision and operational execution. Carrel guides AtriCure's mission to develop and deliver innovative medical technologies for treating Atrial Fibrillation and related conditions. Overseeing all business units, the President & Chief Executive Officer ensures alignment with market demands and long-term growth objectives. This leadership role involves fostering a culture of innovation and driving the company's expansion into new therapeutic areas. By championing advancements in cardiac ablation and surgical solutions, Michael Carrel directly impacts the company's ability to serve patients and healthcare providers worldwide. Ultimately, Carrel secures AtriCure's position as a leader in cardiac surgery.

Angela Wirick, the Chief Financial Officer at AtriCure, directs the company's financial strategy, planning, and reporting. Wirick oversees all fiscal operations, including budgeting, forecasting, and capital allocation to support AtriCure's growth initiatives in cardiac ablation technologies. Managing investor relations and financial compliance, the Chief Financial Officer ensures robust financial health and transparency. This executive position involves analyzing market trends and financial performance to inform strategic decision-making. By maintaining strong financial discipline and exploring investment opportunities, Angela Wirick directly supports AtriCure's mission to advance patient care. Ultimately, Wirick safeguards the company's financial stability and drives sustainable economic growth.

Douglas Seith, the Chief Operating Officer at AtriCure, manages the company's day-to-day operational activities and manufacturing processes. Seith oversees the efficient production and delivery of AtriCure's innovative technologies, ensuring high standards of quality and reliability. Directing global supply chain management and operational scaling, the Chief Operating Officer supports the company's expanding market presence. This critical function involves optimizing internal workflows and enhancing manufacturing capabilities to meet increasing demand for Afib treatments. By ensuring seamless operational execution, Douglas Seith directly contributes to AtriCure's capacity to provide life-changing medical devices. Ultimately, Seith drives operational excellence across the organization.

Karl Dahlquist, the Chief Legal Officer at AtriCure, oversees all legal affairs and ensures compliance with regulatory requirements. Dahlquist manages the company's legal framework, protecting AtriCure's intellectual property and guiding its corporate governance related to medical device innovation. Directing risk management and corporate compliance, the Chief Legal Officer advises leadership on legal implications of business strategies. This role involves navigating complex healthcare regulations and ensuring adherence to industry standards for Afib treatments. By providing expert legal counsel, Karl Dahlquist directly supports AtriCure's commitment to ethical operations and product integrity. Ultimately, Dahlquist fortifies the company's legal standing and mitigates potential risks.